Singapore Immunology Network (SIgN)

A new biomarker in liver tumor may help doctors predict how patients respond to immunotherapy.

The discovery of how aging impacts memory T cells may unlock novel therapeutic targets to boost immune protection in older adults.

These novel immune signatures identify patients most at risk for developing severe COVID-19 symptoms.

Using flow cytometry, researchers have developed a sensitive and specific test for COVID-19 that can identify asymptomatic carriers.

Differences in the skin microbiome could reveal clues as to why some cases of atopic dermatitis are more severe than others.

Being able to distinguish between different types of macrophages in the brain could shed light on inflammatory diseases such as Alzheimer’s.

The structure of collagen fibers may play a key role in the spread of breast cancer, with implications for clinical prognosis and treatment.

Flower-like ‘rosettes’ may help malaria parasites evade the body’s immune defences.

A comprehensive ranking of 14 algorithms may help bioinformaticians overcome inconsistencies during data collection.

A multifaceted study by the Singapore 2019 Novel Coronavirus Outbreak Research team is filling in some of the gaps left in the urgent quest to understand COVID-19 infection.

A*STAR researchers identify new, specific markers of severe COVID-19 that may improve the management and treatment of patients.

New clues into how the immune system remembers a dengue infection may lead to a better vaccine.